Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1634

1.

Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease.

Behnke S, Pilotto A, Liepelt-Scarfone I, Yilmaz R, Pausch C, Dieterich S, Bürmann J, Spiegel J, Dillmann U, Unger M, Posner I, Berg D.

Parkinsonism Relat Disord. 2019 Jul 7. pii: S1353-8020(19)30295-0. doi: 10.1016/j.parkreldis.2019.07.005. [Epub ahead of print]

PMID:
31324557
2.

Fostering Meaning in Residency to Curb the Epidemic of Resident Burnout: Recommendations From Four Chief Medical Residents.

Berg DD, Divakaran S, Stern RM, Warner LN.

Acad Med. 2019 Jul 9. doi: 10.1097/ACM.0000000000002869. [Epub ahead of print]

PMID:
31299672
3.

Gait analysis with wearables predicts conversion to Parkinson's disease.

Del Din S, Elshehabi M, Galna B, Hobert M, Warmerdam E, Suenkel U, Brockmann K, Metzger F, Hansen C, Berg D, Rochester L, Maetzler W.

Ann Neurol. 2019 Jul 11. doi: 10.1002/ana.25548. [Epub ahead of print]

PMID:
31294853
4.

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.

Levin J, Maaß S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Südmeyer M, Eggert K, Mollenhauer B, Lipp A, Löhle M, Classen J, Münchau A, Kassubek J, Gandor F, Berg D, Egert-Schwender S, Eberhardt C, Paul F, Bötzel K, Ertl-Wagner B, Huppertz HJ, Ricard I, Höglinger GU; PROMESA Study Group.

Lancet Neurol. 2019 Aug;18(8):724-735. doi: 10.1016/S1474-4422(19)30141-3. Epub 2019 Jul 2.

PMID:
31278067
5.

Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease.

Schaeffer E, Busch JH, Roeben B, Otterbein S, Saraykin P, Leks E, Liepelt-Scarfone I, Synofzik M, Elshehabi M, Maetzler W, Hansen C, Andris S, Berg D.

Front Neurol. 2019 Jun 19;10:646. doi: 10.3389/fneur.2019.00646. eCollection 2019.

6.

α-Synuclein in Parkinson's disease: causal or bystander?

Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM.

J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25. Review.

PMID:
31240402
7.

In Vitro Culture of Deer Embryos.

Berg DK, Thongphakdee A.

Methods Mol Biol. 2019;2006:191-207. doi: 10.1007/978-1-4939-9566-0_14.

PMID:
31230282
8.

Mediator complex interaction partners organize the transcriptional network that defines neural stem cells.

Quevedo M, Meert L, Dekker MR, Dekkers DHW, Brandsma JH, van den Berg DLC, Ozgür Z, van IJcken WFJ, Demmers J, Fornerod M, Poot RA.

Nat Commun. 2019 Jun 17;10(1):2669. doi: 10.1038/s41467-019-10502-8.

9.

Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study.

Gorges M, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R; LANDSCAPE Consortium, Hilker-Roggendorf R, Berg D, Kunz MS, Kalbe E, Baudrexel S, Kassubek J.

Ther Adv Neurol Disord. 2019 May 16;12:1756286419843447. doi: 10.1177/1756286419843447. eCollection 2019.

10.

Neonatal Nicotine Exposure Primes Midbrain Neurons to a Dopaminergic Phenotype and Increases Adult Drug Consumption.

Romoli B, Lozada AF, Sandoval IM, Manfredsson FP, Hnasko TS, Berg DK, Dulcis D.

Biol Psychiatry. 2019 Apr 24. pii: S0006-3223(19)31289-2. doi: 10.1016/j.biopsych.2019.04.019. [Epub ahead of print]

PMID:
31202491
11.

Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.

Lerche S, Machetanz G, Wurster I, Roeben B, Zimmermann M, Pilotto A, Preische O, Stransky E, Deuschle C, Hauser AK, Schulte C, Lachmann I, Waniek K, Gasser T, Berg D, Maetzler W, Brockmann K.

Mov Disord. 2019 Jul;34(7):1069-1073. doi: 10.1002/mds.27731. Epub 2019 Jun 12.

PMID:
31189032
12.

Deer antler stem cells are a novel type of cells that sustain full regeneration of a mammalian organ-deer antler.

Wang D, Berg D, Ba H, Sun H, Wang Z, Li C.

Cell Death Dis. 2019 Jun 5;10(6):443. doi: 10.1038/s41419-019-1686-y.

13.

Feasibility of EMDR for posttraumatic stress disorder in patients with personality disorders: a pilot study.

Slotema CW, van den Berg DPG, Driessen A, Wilhelmus B, Franken IHA.

Eur J Psychotraumatol. 2019 May 23;10(1):1614822. doi: 10.1080/20008198.2019.1614822. eCollection 2019.

14.

Functional movement disorders in neurogeriatric inpatients : Underdiagnosed, often comorbid to neurodegenerative disorders and treatable.

Mätzold S, Geritz J, Zeuner KE, Berg D, Paschen S, Hieke J, Sablowsky S, Ortlieb C, Bergmann P, Hofmann W, Espay AJ, Maetzler W.

Z Gerontol Geriatr. 2019 Jul;52(4):324-329. doi: 10.1007/s00391-019-01562-y. Epub 2019 May 28. Review.

PMID:
31139963
15.

Dual vs. Single Tasking During Circular Walking: What Better Reflects Progression in Parkinson's Disease?

Micó-Amigo ME, Kingma I, Heinzel S, Nussbaum S, Heger T, van Lummel RC, Berg D, Maetzler W, van Dieën JH.

Front Neurol. 2019 May 14;10:372. doi: 10.3389/fneur.2019.00372. eCollection 2019.

16.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Jul;34(7):975-984. doi: 10.1002/mds.27701. Epub 2019 Apr 29. No abstract available.

PMID:
31034671
17.

Sterile Processing: The Tip of the Sword for Safe, Effective Patient Care.

Berg D.

Biomed Instrum Technol. 2019 Jun;53(s2):5. doi: 10.2345/0899-8205-53.s2.5. No abstract available.

PMID:
31013120
18.

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

van Eimeren T, Antonini A, Berg D, Bohnen N, Ceravolo R, Drzezga A, Höglinger GU, Higuchi M, Lehericy S, Lewis S, Monchi O, Nestor P, Ondrus M, Pavese N, Peralta MC, Piccini P, Pineda-Pardo JÁ, Rektorová I, Rodríguez-Oroz M, Rominger A, Seppi K, Stoessl AJ, Tessitore A, Thobois S, Kaasinen V, Wenning G, Siebner HR, Strafella AP, Rowe JB.

Alzheimers Dement (Amst). 2019 Apr 2;11:301-309. doi: 10.1016/j.dadm.2019.01.011. eCollection 2019 Dec.

19.

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G.

Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

20.

μ-Opioid Receptor Activation Directly Modulates Intrinsically Photosensitive Retinal Ganglion Cells.

Cleymaet AM, Gallagher SK, Tooker RE, Lipin MY, Renna JM, Sodhi P, Berg D, Hartwick ATE, Berson DM, Vigh J.

Neuroscience. 2019 Jun 1;408:400-417. doi: 10.1016/j.neuroscience.2019.04.005. Epub 2019 Apr 11.

PMID:
30981862
21.

Biomarkers of Parkinson's disease: 20 years later.

Yilmaz R, Hopfner F, van Eimeren T, Berg D.

J Neural Transm (Vienna). 2019 Jul;126(7):803-813. doi: 10.1007/s00702-019-02001-3. Epub 2019 Apr 4. Review.

PMID:
30949837
22.

A Dangerous Detour.

Berg DD, Kirshenbaum JM, Gay E, Miller AL, Loscalzo J.

N Engl J Med. 2019 Apr 4;380(14):1360-1365. doi: 10.1056/NEJMcps1803916. No abstract available.

PMID:
30943341
23.

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.

Dimopoulos MA, Laubach JP, Echeveste Gutierrez MA, Grzasko N, Hofmeister CC, San-Miguel JF, Kumar S, Labotka R, Lu V, Berg D, Byrne C, Teng Z, Liu G, van de Velde H, Richardson PG.

Eur J Haematol. 2019 Jun;102(6):494-503. doi: 10.1111/ejh.13231. Epub 2019 May 8.

PMID:
30943323
24.

The Role of Early Biologic Therapy in Inflammatory Bowel Disease.

Berg DR, Colombel JF, Ungaro R.

Inflamm Bowel Dis. 2019 Apr 1. pii: izz059. doi: 10.1093/ibd/izz059. [Epub ahead of print]

PMID:
30934053
25.

A Common Embryonic Origin of Stem Cells Drives Developmental and Adult Neurogenesis.

Berg DA, Su Y, Jimenez-Cyrus D, Patel A, Huang N, Morizet D, Lee S, Shah R, Ringeling FR, Jain R, Epstein JA, Wu QF, Canzar S, Ming GL, Song H, Bond AM.

Cell. 2019 Apr 18;177(3):654-668.e15. doi: 10.1016/j.cell.2019.02.010. Epub 2019 Mar 28.

PMID:
30929900
26.

Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.

Postuma RB, Berg D.

Mov Disord. 2019 May;34(5):665-675. doi: 10.1002/mds.27670. Epub 2019 Mar 28. Review.

PMID:
30919499
27.

A Dangerous Detour.

Berg DD, Kirshenbaum J, Gay E, Vaidya A, Loscalzo J.

N Engl J Med. 2019 Mar 28;380(13):e18. doi: 10.1056/NEJMimc1804660. No abstract available.

PMID:
30917263
28.

Implementing the Knowledge Assessment of CPT Critical Skills (KACCS) Scale.

Atuel HR, Ursich L, Schuyler A, Berg D, Kintzle S, Castro C.

Mil Med. 2019 Mar 1;184(Suppl 1):461-466. doi: 10.1093/milmed/usy341.

PMID:
30901459
29.

A case of CLIPPERS syndrome responsive to tocilizumab.

Rempe T, Becktepe JS, Metz I, Brück W, Stürner KH, Deuschl G, Berg D, Baron R, Zeuner R, Leypoldt F.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 1;6(3):e545. doi: 10.1212/NXI.0000000000000545. eCollection 2019 May. No abstract available.

30.

Epidemiology of Shock in Contemporary Cardiac Intensive Care Units.

Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird-Zars VM, Barnett CF, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis AP, Haleem A, Hollenberg SM, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Park JG, Phreaner N, Roswell RO, Schulman SP, Jeffrey Snell R, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA.

Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005618. doi: 10.1161/CIRCOUTCOMES.119.005618.

PMID:
30879324
31.

The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology.

Keikes L, Medlock S, van de Berg DJ, Zhang S, Guicherit OR, Punt CJA, van Oijen MGH.

J Clin Transl Res. 2018 Jul 27;3(Suppl 3):411-423. eCollection 2018 Dec 17.

32.

Key components of a community response to out-of-hospital cardiac arrest.

Berg DD, Bobrow BJ, Berg RA.

Nat Rev Cardiol. 2019 Jul;16(7):407-416. doi: 10.1038/s41569-019-0175-4. Review.

PMID:
30858511
33.

Potential Markers of Progression in Idiopathic Parkinson's Disease Derived From Assessment of Circular Gait With a Single Body-Fixed-Sensor: A 5 Year Longitudinal Study.

Micó-Amigo ME, Kingma I, Heinzel S, Rispens SM, Heger T, Nussbaum S, van Lummel RC, Berg D, Maetzler W, van Dieën JH.

Front Hum Neurosci. 2019 Feb 19;13:59. doi: 10.3389/fnhum.2019.00059. eCollection 2019.

34.

The NADPH oxidase 4 is a major source of hydrogen peroxide in human granulosa-lutein and granulosa tumor cells.

Buck T, Hack CT, Berg D, Berg U, Kunz L, Mayerhofer A.

Sci Rep. 2019 Mar 5;9(1):3585. doi: 10.1038/s41598-019-40329-8.

35.

In vitro and in silico multidimensional modeling of oncolytic tumor virotherapy dynamics.

Berg DR, Offord CP, Kemler I, Ennis MK, Chang L, Paulik G, Bajzer Z, Neuhauser C, Dingli D.

PLoS Comput Biol. 2019 Mar 5;15(3):e1006773. doi: 10.1371/journal.pcbi.1006773. eCollection 2019 Mar.

36.

Progressive Gait Deficits in Parkinson's Disease: A Wearable-Based Biannual 5-Year Prospective Study.

Hobert MA, Nussbaum S, Heger T, Berg D, Maetzler W, Heinzel S.

Front Aging Neurosci. 2019 Feb 13;11:22. doi: 10.3389/fnagi.2019.00022. eCollection 2019.

37.

Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.

Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, Kootstra NA, Prins M, Ball JK, Bakker AQ, de Jong MD, Spits H, Beaumont T, Schinkel J.

J Hepatol. 2019 Jul;71(1):14-24. doi: 10.1016/j.jhep.2019.02.013. Epub 2019 Feb 21.

PMID:
30797052
38.

Endoscopic versus Surgical Intervention for Jejunal Bezoar Formation.

Berg D, Chakinala RC, Veillette G, Schorr-Lesnick B.

ACG Case Rep J. 2018 Dec 5;5:e87. doi: 10.14309/crj.2018.87. eCollection 2018.

39.

Necroptosis in primate luteolysis: a role for ceramide.

Bagnjuk K, Stöckl JB, Fröhlich T, Arnold GJ, Behr R, Berg U, Berg D, Kunz L, Bishop C, Xu J, Mayerhofer A.

Cell Death Discov. 2019 Feb 11;5:67. doi: 10.1038/s41420-019-0149-7. eCollection 2019.

40.

Split-belt treadmill walking in patients with Parkinson's disease: A systematic review.

Seuthe J, D'Cruz N, Ginis P, Weisser B, Berg D, Deuschl G, Nieuwboer A, Schlenstedt C.

Gait Posture. 2019 Mar;69:187-194. doi: 10.1016/j.gaitpost.2019.01.032. Epub 2019 Feb 7. Review.

PMID:
30771729
41.

Health-economic benefits of treating trauma in psychosis.

de Bont PAJM, van der Vleugel BM, van den Berg DPG, de Roos C, Lokkerbol J, Smit F, de Jongh A, van der Gaag M, van Minnen A.

Eur J Psychotraumatol. 2019 Jan 21;10(1):1565032. doi: 10.1080/20008198.2018.1565032. eCollection 2019.

42.

Less Is More - Estimation of the Number of Strides Required to Assess Gait Variability in Spatially Confined Settings.

Kroneberg D, Elshehabi M, Meyer AC, Otte K, Doss S, Paul F, Nussbaum S, Berg D, Kühn AA, Maetzler W, Schmitz-Hübsch T.

Front Aging Neurosci. 2019 Jan 21;10:435. doi: 10.3389/fnagi.2018.00435. eCollection 2018.

43.

Potential Applications of Digital Technology in Assessment, Treatment, and Self-help for Hallucinations.

Thomas N, Bless JJ, Alderson-Day B, Bell IH, Cella M, Craig T, Delespaul P, Hugdahl K, Laloyaux J, Larøi F, Lincoln TM, Schlier B, Urwyler P, van den Berg D, Jardri R.

Schizophr Bull. 2019 Feb 1;45(45 Suppl 1):S32-S42. doi: 10.1093/schbul/sby103. Review.

44.

Role of ANO3 mutations in dystonia: A large-scale mutational screening study.

Olschewski L, Jesús S, Kim HJ, Tunc S, Löns S, Junker J, Zeuner KE, Kühn AA, Kuhlenbäumer G, Schäffer E, Berg D, Kasten M, Ferbert A, Altenmüller E, Brüggemann N, Bauer P, Rolfs A, Jeon B, Bäumer T, Mir P, Klein C, Lohmann K.

Parkinsonism Relat Disord. 2019 May;62:196-200. doi: 10.1016/j.parkreldis.2018.12.030. Epub 2019 Jan 2.

PMID:
30712998
45.

Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.

Pilotto A, Blau N, Leks E, Schulte C, Deuschl C, Zipser C, Piel D, Freisinger P, Gramer G, Kölker S, Haas D, Burgard P, Nawroth P, Georg H, Scheffler K, Berg D, Trefz F.

J Inherit Metab Dis. 2019 May;42(3):398-406. doi: 10.1002/jimd.12049. Epub 2019 Feb 1.

PMID:
30706953
46.

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance.

Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Rajkumar SV, Richardson PG.

Leukemia. 2019 Jul;33(7):1736-1746. doi: 10.1038/s41375-019-0384-1. Epub 2019 Jan 29.

PMID:
30696949
47.

The principles of tomorrow's university.

Katz DS, Allen G, Barba LA, Berg DR, Bik H, Boettiger C, Borgman CL, Brown CT, Buck S, Burd R, de Waard A, Eve MP, Granger BE, Greenberg J, Howe A, Howe B, Khanna M, Killeen TL, Mayernik M, McKiernan E, Mentzel C, Merchant N, Niemeyer KE, Noren L, Nusser SM, Reed DA, Seidel E, Smith M, Spies JR, Turk M, Van Horn JD, Walsh J.

F1000Res. 2018 Dec 11;7:1926. doi: 10.12688/f1000research.17425.1. eCollection 2018.

48.

Blood-Based Biomarkers of Quinpirole Pharmacology: Cluster-Based PK/PD and Metabolomics to Unravel the Underlying Dynamics in Rat Plasma and Brain.

van den Brink WJ, Hartman R, van den Berg DJ, Flik G, Gonzalez-Amoros B, Koopman N, Elassais-Schaap J, van der Graaf PH, Hankemeier T, de Lange ECM.

CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):107-117. doi: 10.1002/psp4.12370. Epub 2019 Jan 24.

49.

Progress of Pharmacological Approaches in Parkinson's Disease.

Zeuner KE, Schäffer E, Hopfner F, Brüggemann N, Berg D.

Clin Pharmacol Ther. 2019 May;105(5):1106-1120. doi: 10.1002/cpt.1374. Epub 2019 Mar 22.

PMID:
30661251
50.

Minority Resident Physicians' Views on the Role of Race/Ethnicity in Their Training Experiences in the Workplace.

Osseo-Asare A, Balasuriya L, Huot SJ, Keene D, Berg D, Nunez-Smith M, Genao I, Latimore D, Boatright D.

JAMA Netw Open. 2018 Sep 7;1(5):e182723. doi: 10.1001/jamanetworkopen.2018.2723.

Supplemental Content

Support Center